Axos Financial Inc (AX) Stock News

IMAX stock surged 4.33% on Monday after announcing that Christopher Nolan's 'The Odyssey' became the highest-grossing IMAX release of all time with $289 million in ticket sales. The film continues to sell out weeks in advance with nearly $40 million in presales, and IMAX expects this to be its best year ever at the global box office.

The FAA finally certified Boeing's 737 MAX 7 on Monday, seven years after the original 2019 target. The certification clears the way for Boeing to deliver approximately 30 completed aircraft in storage. While the approval is significant for unlocking revenue, the stock's 8% rally was also driven by cheaper oil and a BNP Paribas upgrade. The analyst suggests most of the positive impact is already priced in, with meaningful revenue impact expected in 2027.

Bernstein Liebhard LLP has launched investigations into potential breaches of fiduciary duty by directors and officers at CarMax, Inc., Capricor Therapeutics, Inc., and Calix, Inc. The firm is seeking to determine whether company leadership acted in shareholders' best interests and is encouraging affected shareholders to contact them for legal consultation.

US FAA certifies Boeing 737 MAX 7 in win for planemaker  Reuters

IMAX stock surged 6.60% as the company reported record-breaking performance driven by Christopher Nolan's 'The Odyssey,' which generated $221 million in IMAX ticket sales in July alone. The film achieved the fastest IMAX release to reach $200 million in ticket sales and propelled IMAX to its most successful month in history with $257 million in box-office revenue, 47% higher than the previous record. The company also announced an upcoming IMAX run for 'Spider-Man: Brand New Day' following strong openings in Asian markets.

IMAX stock continues to rise as Christopher Nolan's film 'The Odyssey,' shot entirely with IMAX cameras, becomes a global cultural phenomenon. The film achieved a record-breaking $52 million opening weekend followed by $48 million in its second weekend, with fans traveling across countries to experience it in IMAX 70mm format. Screenings are selling out around the clock, prompting IMAX to extend 70mm showings into mid-September.

Universal and IMAX have extended the availability of 70mm screenings of Christopher Nolan's retelling of Homer's epic into mid-September.

Monteverde & Associates PC is investigating four major M&A transactions on behalf of shareholders: Northrim Bancorp's merger with PBCO Financial Corporation, Neuphoria Therapeutics' merger with Scancell Holdings plc, Safety Insurance Group's sale to a Mapfre affiliate, and RE/MAX Holdings' sale to The Real Brokerage Inc. The firm encourages shareholders to contact them regarding potential concerns with these deals.

IMAX stock surged 11.88% after beating earnings expectations with adjusted earnings of $0.43 per share versus Wall Street's estimate of $0.27. The success of Christopher Nolan's 'The Odyssey,' the first full-length film shot entirely with IMAX cameras, which generated a record $52 million opening weekend, is driving momentum. The company installed 38 systems in Q2 (fastest pace in a decade) and has a backlog of 421 systems, with upcoming blockbusters like 'Dune: Part Three' expected to further accelerate growth.

Nolan's "The Odyssey" is racking up box office dollars for IMAX and fueling investor confidence that the company will reach a record ticket sales in 2026.

SOLOWIN HOLDINGS (Nasdaq: AXG) announced a strategic partnership with ATTRUS to develop financial services in Latin America, focusing on cross-border payments, stablecoin on/off-ramp services, and digital financial infrastructure in Mexico and Brazil. The collaboration combines AXG's blockchain technology and AI-driven payment routing with ATTRUS's local financial networks. Additionally, AX Coin, a subsidiary of AXG, received the first stablecoin issuer license from the Central Bank of Bahrain and partnered with Bank of Bahrain and Kuwait for regulated stablecoin infrastructure.

Griffin Global Asset Management has delivered the first of six Boeing 737 MAX 8 aircraft on long-term lease to VietJet Group. The deal supports VietJet's fleet modernization and expansion strategy with fuel-efficient aircraft.

Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed mergers and acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers.

Bernstein Liebhard LLP, an investor rights law firm, is investigating whether certain directors and officers of CarMax, Inc. breached fiduciary duties owed to the company. The firm is seeking shareholders who purchased shares prior to June 20, 2025, to discuss their legal rights and options.

The DAX has reached record highs, benefiting from a rotation out of US tech into European cyclicals and industrials, which offer better valuations. The FTSE 100 has broken above its symmetrical triangle pattern with M&A activity in focus, including EasyJet's takeover by Castlelake and ITV's sale of its media business to Sky. Both indices are well-positioned as investors question the sustainability of the AI-driven rally and seek value in European equities.

VERAXA Biotech announced substantial progress in its pipeline and partnering strategy, with plans to focus investments on its BiTAC platform for T cell engagers and antibody-drug conjugates. The company aims to have its lead BiTAC-TCE candidate VXA-102 IND/CTA-ready by early 2028 and intends to monetize non-BiTAC assets to finance growth. The company is actively pursuing partnerships and reported strong industry interest in its novel BiTAC technology.

TRADEMARK, a global experiential marketing agency, has won a Bronze Eventex Award for its production and execution work on Adobe MAX 2025, one of the world's largest creative conferences. The award recognizes the agency's ability to blend creative ambition with operational precision in delivering hybrid in-person and digital experiences.

AVAX One Technology Ltd. (Nasdaq: AVX) announced a 12-for-1 reverse stock split effective June 15, 2026, reducing outstanding shares from 92.3 million to 7.7 million. The split was implemented to comply with Nasdaq's minimum closing bid price requirement. The company operates digital infrastructure data centers, Bitcoin mining operations, and maintains an Avalanche digital asset treasury.

VERAXA Biotech AG successfully completed its business combination with Voyager Acquisition Corp and will begin trading on NASDAQ under ticker VRXA on June 11, 2026. The company secured $27.5 million in senior secured note financing and up to $50 million in share purchase agreements to advance its pipeline of BiTAC-TCE and BiTAC-ADC cancer therapies. VERAXA presented promising preclinical data at AACR 2026 demonstrating superior safety profiles and matching efficacy compared to traditional TCEs.

Securities law firm BFA Law announced an investigation into RE/MAX Holdings' board of directors and co-founder David Liniger regarding potential breaches of fiduciary duties in connection with the pending merger with The Real Brokerage Inc. at $13.80 per share. The investigation examines whether the merger price is unfairly low and if insiders are receiving disproportionate benefits compared to public shareholders.

VERAXA Biotech has secured $27.5 million in senior secured note financing and a $50 million share purchase agreement with Lincoln Park Capital Fund to support its business combination with Voyager Acquisition Corp. and advance its pipeline of cancer therapies. VERAXA shareholders have approved the merger and issuance of new shares, with the combined company expected to list on NASDAQ under the ticker 'VRXA'.

Securities law firm Bleichmar Fonti & Auld LLP announced an investigation into RE/MAX Holdings' board of directors and co-founder David Liniger regarding potential breaches of fiduciary duties in connection with the pending merger with The Real Brokerage Inc. The investigation focuses on whether the merger price of $13.80 per share or 5.15 shares of the post-merger entity is unfairly low and whether insiders are receiving disproportionate benefits.

IMAX stock surged 15.47% this week following reports that the entertainment technology company is exploring a potential sale to a larger entertainment company. The jump reflects investor optimism about a possible acquisition, while IMAX continues to benefit from strong demand for its technology platform globally, with 14 'Filmed For IMAX' releases projected to generate $1.4 billion in box office receipts in 2026 and adjusted net income surging 58% in 2025.

A federal jury in Seattle ruled in favor of Boeing, rejecting LOT Polish Airlines' fraud claims that the company concealed safety information about the 737 MAX's MCAS system. LOT sought $153 million in damages, arguing the undisclosed system changes contributed to fatal 2018-2019 crashes. The verdict marks another major legal victory for Boeing as it pursues a potential 750-jet deal with China.

On Friday, a federal jury in Seattle ruled in favor of Boeing Co (NYSE: BA ) , rejecting claims that the aerospace giant concealed critical safety information tied to the 737 MAX system linked to two fatal crashes . Boeing Wins 737 MAX Fraud Case LOT Polish Airlines had accused Boeing of withholding details about changes to the aircraft's flight-control system, known as MCAS, before the jets were delivered last decade, Reuters reported. The airline argued the undisclosed system contributed to the 2018 and 2019 737 MAX crashes that killed hundreds of people and triggered a nearly 20-month worldwide grounding of the aircraft. LOT sought $153 million in damages, saying the grounding caused significant financial losses for the carrier. After a two-week trial in U.S. District Court in Seattle, jurors deliberated for roughly three hours before finding Boeing not guilty of fraud. data-variant="card" data-news-mode="manual" ... Full story available on Benzinga.com

Multiple major M&A transactions and bankruptcies dominated the deal landscape. NextEra Energy agreed to acquire Dominion Energy for $66.8 billion in an all-stock deal. Shein acquired Everlane for $100 million, while Authentic Brands Group bought Lee from Kontoor Brands. IMAX is exploring a potential sale. West Marine, Del Monte Foods, Warrior Technologies, and Bitcoin Depot filed for Chapter 11 bankruptcy. Other notable deals include Medtronic's acquisition of SPR Therapeutics for $650 million and KKR's sale of CIRCOR Aerospace to Parker Hannifin for $2.55 billion.

A source told CNBC that IMAX has held "preliminary talks" through intermediaries, but no official pitches have been made by the company.

IMAX has held "preliminary talks" through intermediaries, but no official pitches have been made directly by the company, a source told CNBC.

IMAX is reportedly exploring a potential sale, approaching entertainment firms about a transaction, though discussions remain early. The company's strong 2025 performance—including record global box office, 166 new theater signings, and expanding content beyond traditional Hollywood—makes it an attractive target. IMAX shares surged 12.16% in after-hours trading.

Telix Pharmaceuticals announced completion of patient enrolment in the IPAX-2 Phase 1 study of TLX101-Tx (¹³¹I-iodofalan) for newly diagnosed glioblastoma. The study reached its maximum dose of 10GBq with no dose-limiting toxicities observed. The company is also advancing the pivotal IPAX BrIGHT Phase 3 trial for recurrent glioblastoma, marking the first radiopharmaceutical therapy to enter Phase 3 development for this indication.